Bobbie J Rimel

Title(s)HS Associate Clinical Professor, Obstetrics and Gynecology
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting. Gynecol Oncol Rep. 2024 Feb; 51:101332. Rimel BJ, Chase DM, Perhanidis J, Ghazarian AA, Du EX, Wang T, Song J, Golembesky AK, Hurteau JA, Kalilani L, Salani R, Monk BJ. PMID: 38362364; PMCID: PMC10867570.
      View in: PubMed   Mentions:
    2. NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer. 2024 Apr 15; 130(8):1234-1245. Rimel BJ, Enserro D, Bender DP, Jackson CG, Tan A, Alluri N, Borowsky M, Moroney J, Hendrickson AW, Backes F, Swisher E, Powell M, MacKay H. PMID: 38127487.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender. SSM Popul Health. 2023 Dec; 24:101540. Lin E, Sleboda P, Rimel BJ, Datta GD. PMID: 37920304; PMCID: PMC10618777.
      View in: PubMed   Mentions:
    4. Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity. Cancer Causes Control. 2024 Jan; 35(1):133-151. Lin E, Sleboda P, Rimel BJ, Chen JT, Hernandez DV, Datta GD. PMID: 37599335; PMCID: PMC10764448.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer. Gynecol Oncol. 2023 08; 175:156-162. Taylor KN, Li A, Manuel M, Rimel BJ, Kim KH. PMID: 37390596.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations. Gynecol Oncol. 2023 07; 174:148-156. Rimel BJ, Crane EK, Hou J, Nakayama J, MacDonald J, Lutz K, Makker V, O'Cearbhaill RE. PMID: 37207499.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer Res Commun. 2022 11; 2(11):1436-1444. Mirza MR, Lindahl G, Mahner S, Redondo A, Fabbro M, Rimel BJ, Herrstedt J, Oza AM, Canzler U, Berek JS, González-Martín A, Follana P, Lord R, Azodi M, Estenson K, Wang Z, Li Y, Gupta D, Matulonis U, Feng B. PMID: 36970052; PMCID: PMC10035404.
      View in: PubMed   Mentions: 1  Translation:HumansCells
    8. Current gaps and opportunities in screening, prevention, and treatment of cervical cancer. Cancer. 2022 Dec 01; 128(23):4063-4073. Rimel BJ, Kunos CA, Macioce N, Temkin SM. PMID: 36239009.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers. J Exp Clin Cancer Res. 2022 Jul 27; 41(1):232. Gull N, Jones MR, Peng PC, Coetzee SG, Silva TC, Plummer JT, Reyes ALP, Davis BD, Chen SS, Lawrenson K, Lester J, Walsh C, Rimel BJ, Li AJ, Cass I, Berg Y, Govindavari JB, Rutgers JKL, Berman BP, Karlan BY, Gayther SA. PMID: 35883104; PMCID: PMC9327231.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study. Int J Gynecol Cancer. 2022 02; 32(2):153-158. Cerda VR, Lu D, Scott M, Kim KH, Rimel BJ, Kamrava M. PMID: 34911701.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100804. Gay C, Raphael YR, Steers J, Lu DJ, Lewis JH, DeMarco J, Fraass B, Rimel BJ, Zakariaee R, Kamrava M, Atkins KM. PMID: 35079662; PMCID: PMC8767263.
      View in: PubMed   Mentions: 1  
    12. Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer. PLoS One. 2021; 16(6):e0252665. Walsh CS, Kamrava M, Rogatko A, Kim S, Li A, Cass I, Karlan B, Rimel BJ. PMID: 34081738; PMCID: PMC8174738.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    13. Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers. Am Surg. 2020 Oct; 86(10):1243-1247. Fong A, Cass I, John C, Gillen J, Moore KM, Gangi A, Walsh C, Li AJ, Rimel BJ, Karlan BY, Amersi F. PMID: 33106023.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019 10; 155(1):39-50. Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD. PMID: 31427143; PMCID: PMC7537353.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2019 05; 20(5):636-648. Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ. PMID: 30948273.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCTClinical Trials
    16. Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination. Cancer Res. 2019 05 15; 79(10):2662-2668. Aryal NK, Pant V, Wasylishen AR, Rimel BJ, Baseler L, El-Naggar AK, Mutch DG, Goodfellow PJ, Arur S, Lozano G. PMID: 30914430; PMCID: PMC6522273.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    17. Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget. 2018 Jun 19; 9(47):28757-28771. Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, Wright JD. PMID: 29983894; PMCID: PMC6033337.
      View in: PubMed   Mentions: 17     Fields:    
    18. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 04; 118(8):1123-1129. Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Australian Ovarian Cancer Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Jung AY, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, du Bois A, Harter P, Schwaab I, Karlan BY, Lester J, Orsulic S, Rimel BJ, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera EV, Olson SH, Salvesen HB, Thomsen LCV, Kopperud RK, Bjorge L, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubinski J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska A, Rzepecka IK, Webb PM, Ovarian Cancer Association Consortium. PMID: 29555990; PMCID: PMC5931085.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts. Gynecol Oncol. 2017 09; 146(3):443-448. Rimel BJ, Gibson SJ, Sumner DA, Monk BJ. PMID: 28693948.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. The American Society of Clinical Oncology 2016 annual meeting: A review and summary of selected abstracts. Gynecol Oncol. 2017 Jan; 144(1):e1-e7. Rimel BJ, Gibson SJ, Sumner DA, Monk BJ. PMID: 27823770.
      View in: PubMed   Mentions:    Fields:    
    21. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 12 01; 375(22):2154-2164. Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Madry R, Christensen RD, Berek JS, Dørum A, Tinker AV, du Bois A, González-Martín A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA, ENGOT-OV16/NOVA Investigators. PMID: 27717299.
      View in: PubMed   Mentions: 934     Fields:    Translation:HumansCTClinical Trials
    22. Adnectin-targeted inhibitors: rationale and results. Curr Oncol Rep. 2015 Aug; 17(8):35. Sachdev E, Gong J, Rimel B, Mita M. PMID: 26045129.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    23. Breast cancer following ovarian cancer in BRCA mutation carriers. JAMA Surg. 2014 Dec; 149(12):1306-13. Gangi A, Cass I, Paik D, Barmparas G, Karlan B, Dang C, Li A, Walsh C, Rimel BJ, Amersi FF. PMID: 25372568.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Bobbie's Networks
    Concepts (117)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California